B-SOFT Co Ltd

B-SOFT's capital structure is characterized by a low debt-to-equity ratio of 0.02, indicating a conservative leverage profile. However, the company's liquidity is rated as medium, and its free cash flow is negative at -390.36 million CNY, suggesting cash flow constraints. The current ratio of 2.38 implies the company has sufficient current assets to cover its short-term liabilities, but the negative operating cash flow of -21.20 million CNY raises concerns about its ability to sustain operations without external financing.

Profitability metrics are deeply negative, with a return on equity of -10.02% and a return on assets of -7.61%. These figures are well below the typical performance of companies in the healthcare equipment industry, which usually exhibit positive returns due to high-margin medical device sales and services. The company's operating income is negative at -414.31 million CNY, and its net income is also negative at -401.65 million CNY, indicating a significant loss-making position.

Geographic and segment exposure data is not available in the provided dataset, but the company's revenue concentration is likely to be within China, given its listing on the Shenzhen Stock Exchange. The absence of disclosed segments limits the ability to assess diversification or growth drivers within the business.

The company's growth trajectory is uncertain, with no specific outlook provided for the current or next fiscal year. Historical revenue data shows a total of 1.05 billion CNY in revenue, but the negative operating and net income figures suggest a challenging operating environment. Analysts have assigned a mean price target of 6.37 CNY, with a median of 6.38 CNY, and a strong buy recommendation from two analysts, indicating some optimism despite the company's current financial performance.

Risk factors include liquidity constraints and the potential for dilution, although the latter is currently rated as low. The company's negative free cash flow and negative operating cash flow increase the risk of needing to raise additional capital, which could lead to equity dilution. The risk assessment also flags that net cash is negative after subtracting total debt, further highlighting the company's financial vulnerability.

Recent events and filings have not been disclosed in the provided data, so it is not possible to assess any material developments in the company's operations or strategy. The absence of recent transcript data or regulatory filings limits the ability to evaluate management's guidance or strategic direction.